AgeX Therapeutics Q3 EPS $(0.06) Down From $(0.05) YoY
Author: Benzinga Newsdesk | November 10, 2022 05:55pm
AgeX Therapeutics (AMEX:AGE) reported quarterly losses of $(0.06) per share. This is a 20 percent decrease over losses of $(0.05) per share from the same period last year.